Lung Cancer News

• Despite Skeptics, At-Home Chemo Programs Continue Growing A handful of US cancer centers believe that many cancer patients can receive their treatment at home. But is it safe?
  Medscape Medical News, February 24, 2021
• Alert FDA Approves Cemiplimab-rwlc for NSCLC With PD-L1 Expression The FDA has approved cemiplimab-rwlc as monotherapy for first-line treatment of advanced non–small cell lung cancer (NSCLC) with PD-L1 expression of at least 50%.
  FDA Approvals, February 24, 2021
• Cancer Death Rates Continue to Fall in Europe, Except For... Cancer death rates overall continue to fall in the EU, with the exception of pancreatic cancer in both sexes and lung cancer among women.
  Medscape Medical News, February 23, 2021
• EU Sues More Countries Over Air Pollution, Nature and Water The European Commission said on Thursday it was suing Slovakia for years-long breaches of legal limits on air pollution and started legal action against Germany and Slovenia for falling short on nature conservation and water treatment.
  Reuters Health Information, February 18, 2021
• Rush Limbaugh Dies at 70 Following Lung Cancer Diagnosis Rush Limbaugh, for decades a popular, controversial, and influential talk radio host and conservative commentator, died Wednesday, according to a family statement.
  WebMD Health News, February 17, 2021
• Cancer Warning Labels on Alcohol: Calls for Congress to Act The American Society of Clinical Oncology (ASCO) and seven other organizations are lobbying Congress to add a warning about cancer risk to all alcoholic beverages.
  Medscape Medical News, February 17, 2021
• Alert First Drug That Protects Against Chemo-Induced Myelosuppression The FDA has approved trilaciclib (Cosela), a first-in-class drug given before chemotherapy to protect against chemo-induced bone marrow suppression.
  FDA Approvals, February 15, 2021
• Nearly 4 in 10 Cancer Deaths Attributable to Cigarette Smoking Rates vary around the US, but nearly 4 in 10 cancer deaths are attributable to cigarette smoking in parts of the South and Appalachia.
  Medscape Medical News, February 12, 2021
• ASCO Endorses Guidelines on Radiation Therapy for SCLC The American Society of Clinical Oncology (ASCO) has endorsed guidelines on radiation therapy for patients with small cell lung cancer (SCLC).
  Medscape Medical News, February 12, 2021
• WCLC 2020 Amivantamab Shows Promise in Challenging EGFR-Mutated NSCLC The novel drug appears to be effective for patients with EGFR-mutated NSCLC that has a hard-to-treat exon 20 insertion after disease progression with platinum-based chemotherapy.
  Medscape Medical News, February 11, 2021
• WCLC 2020 Neoadjuvant Atezolizumab Safe in Resectable Lung Cancer In the LCMC3 study, patients received 1200 mg of neoadjuvant atezolizumab IV every 3 weeks for two cycles followed by resection between 30 and 50 days from the first cycle.
  Medscape Medical News, February 10, 2021
• WCLC 2020 Customized Chemotherapy Did Not Improve Survival in Early NSCLC Tailoring adjuvant chemotherapy based on the expression of two molecular markers did not confer a survival advantage in patients with completely resected stage 2-3 NSCLC in a phase 3 trial.
  Medscape Medical News, February 10, 2021
• WCLC 2020 Combo Immunotherapy in NSCLC: Not These Two Drugs Pembrolizumab monotherapy remains a standard of care, after trial results show that adding ipilimumab conveys no benefits but incurs greater toxicity.
  Medscape Medical News, February 10, 2021
• Beyond COVID-19: Can mRNA Treat Diseases, Too? Now, scientists and researchers are looking to harness mRNA for a tantalizingly greater purpose: treating chronic illnesses.
  WebMD Health News, February 10, 2021
• 'We Can Do Better': COVID-19 Vaccination in Cancer Patients Patients with cancer should be prioritized for COVID vaccination, but only one third of state health departments have heeded the call. Mechanisms to find eligible patients, say advocates, are lacking.
  Medscape Medical News, February 09, 2021
• WCLC 2020 'Unprecedented' Long-term Survival After IO in Pretreated NSCLC For patients with non–small cell lung cancer (NSCLC) who experience disease progression with chemotherapy, immunotherapy (IO) offers an "unprecedented" chance of long-term survival, says an expert.
  Medscape Medical News, February 09, 2021
• WCLC 2020 Sotorasib in NSCLC: 'Historic Milestone' Reached The KRAS inhibitor sotorasib provides durable clinical benefit in heavily pretreated patients with non–small cell lung cancer (NSCLC) harboring KRAS p.G12C mutations, results of a phase 2 trial suggest.
  Medscape Medical News, February 09, 2021
• Alert FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC The US Food and Drug Administration has granted accelerated approval for tepotinib for the treatment of adults with metastatic non–small cell lung cancer harboring MET exon 14 skipping alterations.
  FDA Approvals, February 04, 2021
• Breast Cancer Overtakes Lung as Most Common Cancer: WHO Breast cancer has overtaken lung cancer as the most common form of the disease, accounting for nearly 12% of new cases each year worldwide, the World Health Organisation said on Tuesday.
  Reuters Health Information, February 02, 2021
• WCLC 2020 COVID Has Led to a Drop in Lung Cancer Diagnosis, More Deaths A study from Spain demonstrates the clear and significant negative impact the COVID-19 pandemic is having on lung cancer diagnosis and outcomes.
  Reuters Health Information, February 01, 2021